Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rostelecom bought a data center for 4,000 racks

8/14/24 RTKM

Board of Directors of Tatneft recommended dividends

8/14/24 TATN

Seligdar doubles the capacity of the Buryatia mill

8/14/24 SELG

Inter RAO reported for 6 months of 2024 by IFRS

8/14/24 IRAO

MKB reported for 6 months of 2024 by IFRS

8/14/24 CBOM

Softline started the second stage of Noventiq receipts exchange

8/14/24 SOFL

Rostelecom reported for 6 months of 2024 by IFRS

8/14/24 RTKM

Polyus released the first carbon units

8/13/24 PLZL

Abrau-Durso reported for 6 months of 2024 by RAS

8/13/24 ABRD

Non-residents bought ₽8.1 billion worth of securities from private investors

8/13/24 MOEX